CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 69 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2021. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $152,232 | -22.3% | 175,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $196,000 | +7.7% | 175,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $182,000 | -7.1% | 175,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $196,000 | -0.5% | 175,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $197,000 | -23.3% | 175,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $257,000 | -35.8% | 175,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $400,000 | -16.8% | 175,000 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $481,000 | -54.2% | 175,000 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $1,050,000 | +23.2% | 175,000 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $852,000 | +97.2% | 175,000 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $432,000 | -9.8% | 175,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $479,000 | +78.1% | 175,000 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $269,000 | -18.2% | 175,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $329,000 | +10.8% | 175,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $297,000 | -41.4% | 175,000 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $507,000 | +360.9% | 175,000 | 0.0% | 0.00% | +200.0% |
| Q3 2019 | $110,000 | -35.3% | 175,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $170,000 | -29.5% | 175,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $241,000 | +28.9% | 175,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $187,000 | -82.6% | 175,000 | 0.0% | 0.00% | -83.3% |
| Q3 2018 | $1,076,000 | -42.5% | 175,000 | 0.0% | 0.01% | -45.5% |
| Q2 2018 | $1,870,000 | -0.4% | 175,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $1,877,000 | -23.4% | 175,000 | -50.0% | 0.01% | -15.4% |
| Q4 2017 | $2,450,000 | -19.9% | 350,000 | 0.0% | 0.01% | -27.8% |
| Q3 2017 | $3,059,000 | -4.0% | 350,000 | 0.0% | 0.02% | -5.3% |
| Q2 2017 | $3,188,000 | +14.7% | 350,000 | 0.0% | 0.02% | +11.8% |
| Q1 2017 | $2,779,000 | +210.9% | 350,000 | +250.0% | 0.02% | +240.0% |
| Q4 2016 | $894,000 | – | 100,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
| RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
| EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
| Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
| Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
| CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
| Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |